{{Rsnum
|rsid=11191439
|Gene=AS3MT
|Chromosome=10
|position=104638723
|Orientation=plus
|GMAF=0.08173
|Gene_s=AS3MT,CCDC81
|Assembly=GRCh37.p5
|GenomeBuild=37.3
|dbSNPBuild=137
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.9 | 19.5 | 79.6
| HCB | 0.0 | 2.9 | 97.1
| JPT | 0.0 | 5.3 | 94.7
| YRI | 1.4 | 15.6 | 83.0
| ASW | 1.8 | 24.6 | 73.7
| CHB | 0.0 | 2.9 | 97.1
| CHD | 0.0 | 0.9 | 99.1
| GIH | 0.0 | 10.9 | 89.1
| LWK | 0.0 | 11.8 | 88.2
| MEX | 0.0 | 12.1 | 87.9
| MKK | 2.6 | 15.4 | 82.1
| TSI | 1.0 | 20.6 | 78.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=22747749
|Title=Genetic variation in Glutathione S-Transferase Omega-1, Arsenic Methyltransferase and Methylene-tetrahydrofolate Reductase, arsenic exposure and bladder cancer: a case-control study
|OA=1
}}

{{PMID Auto
|PMID=17889916
|Title=Population differences in the human arsenic (+3 oxidation state) methyltransferase (AS3MT) gene polymorphism detected by using genotyping method.
}}

{{PMID Auto
|PMID=19538983
|Title=Association of AS3MT polymorphisms and the risk of premalignant arsenic skin lesions.
|OA=1
}}

{{PMID Auto
|PMID=22339537
|Title=GSTO and AS3MT genetic polymorphisms and differences in urinary arsenic concentrations among residents in Bangladesh.
|OA=1
}}

{{GET Evidence
|gene=AS3MT
|aa_change=Met287Thr
|aa_change_short=M287T
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs11191439
|overall_frequency_n=1038
|overall_frequency_d=9690
|overall_frequency=0.107121
|n_genomes=14
|n_genomes_annotated=0
|n_haplomes=16
|n_articles=0
|n_articles_annotated=0
|nblosum100=2
|autoscore=0
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}